Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

The altered pharmacokinetic properties of, e.g., aminoglycosides in cystic fibrosis patients have to be considered when pulmonary exacerbations are treated. Since reported data on ciprofloxacin, a fluorinated quinolone, are conflicting, we compared intravenous and oral administration in cystic fibro...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Christensson, B A, Nilsson-Ehle, I, Ljungberg, B, Lindblad, A, Malmborg, A S, Hjelte, L, Strandvik, B
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1992
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284363/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1489195/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.11.2512
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!